We develop treatment methods with unique properties in the therapeutic fields of migraine, pain related to cancer, opioid overdose and anaphylactic shock.
Download the Company Description.
Year end report, 2019
Today, Klaria announces continued operational progress with the lead program, Sumatriptan Alginate Film (KL-00119). In the KL-00119 program, manufacturing work has...
We are using cookies to optimize your browsing experience. By continuing your browsing you consent to such use.